Eaton Vance Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $431K | Sell |
|
|||||
|
2022
Q2 | $448K | Sell |
|
|||||
|
2022
Q1 | $639K | Sell |
|
|||||
|
2021
Q4 | $932K | Buy |
|
|||||
|
2021
Q3 | $697K | Buy |
|
|||||
|
2021
Q2 | $724K | Buy |
|
|||||
|
2021
Q1 | $770K | Sell |
|
|||||
|
2020
Q4 | $33.8M | Buy |
|
|||||
|
2020
Q3 | $22.8M | Buy |
|
|||||
|
2020
Q2 | $24M | Buy |
|
|||||
|
2020
Q1 | $13.4M | Buy |
|
|||||
|
2019
Q4 | $17.8M | Buy |
|
|||||
|
2019
Q3 | $13.3M | Buy |
|
|||||
|
2019
Q2 | $13.5M | Buy |
|
|||||
|
2019
Q1 | $8.89M | Sell |
|
|||||
|
2018
Q4 | $9.66M | Buy |
|
|||||
|
2018
Q3 | $16.9M | Sell |
|
|||||
|
2018
Q2 | $15.8M | Sell |
|
|||||
|
2018
Q1 | $35.7M | Buy |
|
|||||
|
2017
Q4 | $19.2M | Sell |
|
|||||
|
2017
Q3 | $25M | Sell |
|
|||||
|
2017
Q2 | $24.1M | Sell |
|
|||||
|
2017
Q1 | $21M | Buy |
|
|||||
|
2016
Q4 | $9.34M | Buy |
|
|||||
|
2016
Q3 | $2.19M | Buy |
|